Simplex Trading
STML

Simplex Trading’s Stemline Therapeutics, Inc. STML Stock Holding History

Simplex Trading’s Portfolio STML Stock Details STML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-40
Closed -$19K – 8781
2020
Q1 		$19K Sell
40
-82
-67% -$532 ﹤0.01% 6022
2019
Q4 		$129K Sell
122
-46
-27% -$457 ﹤0.01% 4240
2019
Q3 		$174K Buy
168
+23
+16% +$301 ﹤0.01% 3708
2019
Q2 		$222K Sell
145
-325
-69% -$4.7K ﹤0.01% 3364
2019
Q1 		$603K Buy
470
+305
+185% +$3.45K ﹤0.01% 2473
2018
Q4 		$156K Sell
165
-35
-18% -$454 ﹤0.01% 3416
2018
Q3 		$332K Sell
200
-3
-1% -$48 ﹤0.01% 3055
2018
Q2 		$325K Buy
203
+26
+15% +$464 ﹤0.01% 2920
2018
Q1 		$33K Buy
+177
New +$2.76K ﹤0.01% 2862
2017
Q4 		– Sell
-34
Closed -$3K – 7058
2017
Q3 		$3K Sell
34
-20
-37% -$188 ﹤0.01% 4935
2017
Q2 		$10K Sell
54
-4
-7% -$33 ﹤0.01% 4023
2017
Q1 		$22K Buy
+58
New +$529 ﹤0.01% 3167

Simplex Trading's STML Position: Q2 2020 in Review

Simplex Trading sold out of Stemline Therapeutics, Inc. (STML) in Q2 2020, closing a stake of 2,172 shares — an estimated $10K sold.

Simplex Trading first reported a position in STML in Q1 2016 and held it in 14 quarters. The position peaked at $344K in Q4 2018. 0 funds tracked by Wall St. Rank hold STML as of Q2 2020.

  • Simplex Trading reported no remaining Stemline Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
  • Simplex Trading sold 2,172 Stemline Therapeutics, Inc. shares in Q2 2020, an estimated $10K.
  • Simplex Trading first reported a position in Stemline Therapeutics, Inc. in Q1 2016 and held it in 14 quarters.
  • Simplex Trading's Stemline Therapeutics, Inc. position peaked at $344K in Q4 2018.
  • 0 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2020.

Based on Simplex Trading's 13F filing for Q2 2020, filed 13 Jul 2020.